122 related articles for article (PubMed ID: 15937770)
1. Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative.
Laurent C; Meilo H; Guiard-Schmid JB; Mapouré Y; Noël JM; M'Bangué M; Joko A; Rozenbaum W; Ntoné FN; Delaporte E
Clin Infect Dis; 2005 Jul; 41(1):108-11. PubMed ID: 15937770
[TBL] [Abstract][Full Text] [Related]
2. Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients.
Landman R; Damond F; Gerbe J; Brun-Vezinet F; Yeni P; Matheron S
AIDS; 2009 Jan; 23(3):426-8. PubMed ID: 19114866
[TBL] [Abstract][Full Text] [Related]
3. Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.
Sanchez R; Portilla J; Gimeno A; Boix V; Llopis C; Sanchez-Paya J; Merino E; de la Sen ML; Muñoz C; Reus S; Plazas J
J Infect; 2007 Feb; 54(2):159-66. PubMed ID: 16690132
[TBL] [Abstract][Full Text] [Related]
4. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment.
Kouanfack C; Montavon C; Laurent C; Aghokeng A; Kenfack A; Bourgeois A; Koulla-Shiro S; Mpoudi-Ngole E; Peeters M; Delaporte E
Clin Infect Dis; 2009 May; 48(9):1318-22. PubMed ID: 19320592
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART.
Collazos J; Asensi V; Cartón JA
AIDS; 2007 Apr; 21(7):835-43. PubMed ID: 17415038
[TBL] [Abstract][Full Text] [Related]
6. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
7. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
9. [Measure of effectiveness and adherence to antiretroviral therapy in HIV-infected patients in Cameroon].
Mahy S; Duong M; Huraux JM; Aurenche C; Ndong JG; Birguel J; Piroth L; Chavanet P
Med Mal Infect; 2011 Apr; 41(4):176-80. PubMed ID: 20650582
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a home-delivery service for HIV-infected patients attending an inner London HIV treatment centre.
Harte D; Hamill M; Edwards SG; Copas AJ; Minton J; Jones VL; Allason-Jones E; Williams IG; Miller RF
Int J STD AIDS; 2008 Aug; 19(8):533-5. PubMed ID: 18663039
[TBL] [Abstract][Full Text] [Related]
11. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
12. Intermittent antiretroviral therapy in patients with controlled HIV infection.
Marchou B; Tangre P; Charreau I; Izopet J; Girard PM; May T; Ragnaud JM; Aboulker JP; Molina JM;
AIDS; 2007 Feb; 21(4):457-66. PubMed ID: 17301564
[TBL] [Abstract][Full Text] [Related]
13. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
[TBL] [Abstract][Full Text] [Related]
14. Clinical audit: virological and immunological response to combination antiretroviral therapy in HIV patients at a Sydney sexual health clinic.
Hsu DC; Quin JW
Intern Med J; 2010 Apr; 40(4):265-74. PubMed ID: 19460050
[TBL] [Abstract][Full Text] [Related]
15. Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings?
Bagchi S; Kempf MC; Westfall AO; Maherya A; Willig J; Saag MS
Clin Infect Dis; 2007 Jan; 44(1):135-8. PubMed ID: 17143829
[TBL] [Abstract][Full Text] [Related]
16. The development of artificial neural networks to predict virological response to combination HIV therapy.
Larder B; Wang D; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; Monforte AD; Torti C; Zazzi M; Lane C
Antivir Ther; 2007; 12(1):15-24. PubMed ID: 17503743
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
18. Early assessment of the implementation of a national programme for the prevention of mother-to-child transmission of HIV in Cameroon and the effects of staff training: a survey in 70 rural health care facilities.
Labhardt ND; Manga E; Ndam M; Balo JR; Bischoff A; Stoll B
Trop Med Int Health; 2009 Mar; 14(3):288-93. PubMed ID: 19187522
[TBL] [Abstract][Full Text] [Related]
19. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.
Chiappini E; Galli L; Tovo PA; Gabiano C; Gattinara GC; Guarino A; Badolato R; Giaquinto C; Lisi C; de Martino M;
AIDS; 2006 Jan; 20(2):207-15. PubMed ID: 16511413
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patients.
Ribera E; Rodríguez-Pardo D; Rubio M; Soler A; Pedrol E; Blanco JL; González A; Crespo M; Falcó V; Ocaña I; Deig E; Miró JM; Pahissa A
Antivir Ther; 2005; 10(5):605-14. PubMed ID: 16152754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]